# Seizure Advisory System Feasibility Study

> **NCT01043406** · PHASE1 · TERMINATED · sponsor: **NeuroVista Corporation** · enrollment: 15 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DEVICE:** Seizure Advisory System

## Key facts

- **NCT ID:** NCT01043406
- **Lead sponsor:** NeuroVista Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Sponsor restructuring.
- **Last updated:** 2012-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043406, "Seizure Advisory System Feasibility Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01043406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*